Stephane Steurbaut

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

ORCID

Google Scholar

Academic Page

Articles (14)

Medication Review: What’s in a Name and What Is It about?

Article Link

Year:

2024

The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Article Link

Year:

2024

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study

Article Link

Year:

2023

Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study

Article Link

Year:

2023

Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance

Article Link

Year:

2023

Development and partial validation of Be-CLIPSS: a classification system for hospital clinical pharmacy activities

Article Link

Year:

2023

Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism

Article Link

Year:

2023

Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs

Article Link

Year:

2023

Patient experiences and opinions on medication review: a qualitative study

Article Link

Year:

2023

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019

Article Link

Year:

2023

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists

Article Link

Year:

2023

Interception of chronic medication discrepancies by the clinical pharmacist in the emergency department

Article Link

Year:

2023

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation

Article Link

Year:

2023

Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study

Article Link

Year:

2023

Collaborators (5)

Lies Lahousse

Professor at Ghent University

Ghent University

BELGIUM

Hans De Loof

University of Antwerp

BELGIUM

Guido R. Y. De Meyer

University of Antwerp

BELGIUM

Sofie Pauwels

Vrije Universiteit Brussel

BELGIUM

Souad Moudallel

Vrije Universiteit Brussel

BELGIUM

Stephane Steurbaut

Research Interests

Explore related searches

Contact this professor

Articles (14)

Medication Review: What’s in a Name and What Is It about?

The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study

Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study

Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance

Development and partial validation of Be-CLIPSS: a classification system for hospital clinical pharmacy activities

Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism

Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs

Patient experiences and opinions on medication review: a qualitative study

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists

Interception of chronic medication discrepancies by the clinical pharmacist in the emergency department

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation

Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study

Collaborators (5)

Lies Lahousse

Hans De Loof

Guido R. Y. De Meyer

Sofie Pauwels

Souad Moudallel

How do I reach out?

Meet Kite AI